Abdelsadek Mohamed sold $65K of TRU

TransUnion (TRU) reported Q3 2026 earnings beating guidance with 8% revenue growth and 14% EPS growth. International business grew 10%, led by India and Latin America. The company reduced its leverage ratio and increased share repurchase authorization. However, rising interest rates are expected to slow mortgage volumes and auto affordability, leading to a sequential deceleration in revenue growth to 3-6% in Q4. Legal and regulatory expenses also contributed to margin contraction.

TransUnion reported Q3 2026 revenue of $1.31B, up 12.2% YoY, with net income of $156.2M and EPS of $0.81. Growth was driven by U.S. and International segments, including recent acquisitions. Adjusted EBITDA rose 9.3%, but margins declined due to higher costs. Management expects elevated mortgage rates to impact U.S. housing activity.

TransUnion (TRU) reported Q3 2026 revenue, adjusted EBITDA, and adjusted diluted earnings per share above guidance. The company expects 8%-9% organic constant currency revenue growth for 2026 and plans $500M in share buybacks. According to CEO Christopher Cartwright, growth was broad-based.

TransUnion (TRU) reported Q3 2026 organic revenue growth of 8%, with adjusted EPS up 14%. U.S. Markets revenue rose 7%, while international revenue grew 10%, led by India and Latin America. The company repurchased $126M in shares and raised its repurchase authorization by $1B. Despite economic uncertainties, TRU raised its full-year guidance, expecting 8-9% revenue growth and 12-13% adjusted EPS growth.

TransUnion reported Q3 2026 earnings, highlighting 18% growth in India and Latin America, 13% auto growth, and 10% international growth. The company expects full-year share repurchases of $500M and plans to expand its OneTru platform globally. Management noted resilience in US Financial Services despite inflation and higher interest rates, and provided guidance for Q4, including potential impacts from regulatory changes and market softening.

TransUnion (TRU) reported Q3 2026 earnings with revenue of $1.31B, matching estimates, and EPS of $1.25, beating forecasts. Revenue grew 8% organically, driven by insurance and international markets. However, adjusted EBITDA margin contracted by 90 basis points to 35.4%. The company raised full-year guidance, expecting 8-9% revenue growth and 12-13% EPS growth. Shares fell 2.19% in premarket trading.